Delivery Order SPE2DB22D3501-SPE2DB26FTF17
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $2,954.20. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $1,533.52 and a completion date of September 18, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's broader federal supply arrangement. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $31,845.97. This firm fixed-price delivery order, which is expected to be completed by August 12, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a delivery order valued at $1,313.78 to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector (two-pack) on July 29, 2025, with completion expected by July 30, 2025. This firm fixed price delivery order carries no set-aside designation and represents a competitive award to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,927.97 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This non-set-aside, competitively awarded contract is classified as a Delivery Order under a Firm Fixed Price arrangement, with an ultimate completion date of September 10, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $7,489.37 and an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's Conshohocken, Pennsylvania location. The award represents a competitively awarded transaction under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $1,392.30. This is a firm fixed price delivery order with an ultimate completion date of October 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award used no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a contract ceiling value of $1,046.06. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) with a ceiling value of $1,308.27. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 13, 2025. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTF17Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, valued at $1,209.24. This is a firm fixed price delivery order with no set-aside designation, placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order is scheduled for completion by October 23, 2025, with performance centered at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, particularly for military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for the Defense Health Agency and other federal health programs, maintains a $999.99 billion IDC with DLA Troop Support Medical through December 2026. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive pharmaceutical procurement requirements across multiple therapeutic domains, including emergency medical supplies such as auto-injectors for anaphylaxis treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/22/25 |